The Growing Power of Biotech Monopolies Threatens Affordable Care
<p>The U.S. spends well more on prescription drugs, per capita, than any other country in the world. This has long been a source of concern for American patients struggling to afford their medicines.</p>
<p>There are, however, those who argue that high drug prices are justified by a “social contract” under which drug companies can—and should—charge high prices while their drugs are protected by patent monopolies, in exchange for those medicines becoming effectively free once their patents have expired.</p>
<p><a href="https://freopp.org/the-growing-power-of-biotech-monopolies-threatens-affordable-care-e75e36fa1529"><strong>Website</strong></a></p>